CIK: 0001694620
Total reported value
$8.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 16.60% | — | -10.85% | |
| 2 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 13.74% | — | -8.85% | |
| 3 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 11.18% | — | -32.89% | |
| 4 | CI | THE Cigna Group | Stock-Healthcare | 10.72% | — | — | |
| 5 | ABBV | Abbvie INC | Stock-Healthcare | 8.93% | — | -41.70% | |
| 6 | IQV | Iqvia Holdings INC | Stock-Healthcare | 8.22% | — | -30.01% | |
| 7 | ZTS | Zoetis INC | Stock-Healthcare | 5.26% | — | -0.20% | |
| 8 | SIENUSD | Sientra INC | Stock-Other | 4.51% | — | -0.05% | |
| 9 | TMO | Thermo Fisher Scientific INC | Stock-Healthcare | 4.24% | — | -65.63% | |
| 10 | FATE | Fate Therapeutics INC | Stock-Other | 4.16% | — | +115.97% | |
| 11 | TNDM | Tandem Diabetes Care INC | Stock-Other | 3.91% | — | — | |
| 12 | ✓ | Stock-Other | 2.57% | — | — | ||
| 13 | ASND | Ascendis Pharma A/S | Stock-Other | 2.19% | — | — | |
| 14 | HUM | Humana INC | Stock-Healthcare | 1.89% | — | -87.28% | |
| 15 | ILMN | Illumina INC | Stock-Healthcare | 1.87% | — | -53.75% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals INC | +6.4% | -10.85% | Trim |
| 2 | BMRN | Biomarin Pharmaceutical INC | +5.2% | -8.85% | Trim |
| 3 | FATE | Fate Therapeutics INC | +3.1% | +115.97% | Add |
| 4 | SIENUSD | Sientra INC | +2.2% | -0.05% | Trim |
| 5 | BMY | Bristol-myers Squibb Co | +1.8% | -32.89% | Trim |
| 6 | ZTS | Zoetis INC | +1.7% | -0.20% | Trim |
| 7 | IQV | Iqvia Holdings INC | +0.2% | -30.01% | Trim |
| 8 | ABBV | Abbvie INC | -0.4% | -41.70% | Trim |
| 9 | ILMN | Illumina INC | -0.8% | -53.75% | Trim |
| 10 | TMO | Thermo Fisher Scientific INC | -3.6% | -65.63% | Trim |
| 11 | HUM | Humana INC | -5.5% | -87.28% | Trim |
| 12 | GILD | Gilead Sciences INC | — | EXIT | Sold out |
| 13 | CI | THE Cigna Group | — | NEW | New buy |
| 14 | CNC | Centene CORP | — | EXIT | Sold out |
| 15 | MRK | Merck & Co. INC. | — | EXIT | Sold out |
| 16 | CDNA | Caredx INC | — | EXIT | Sold out |
| 17 | TNDM | Tandem Diabetes Care INC | — | NEW | New buy |
| 18 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 19 | ✓ | — | NEW | New buy | |
| 20 | ASND | Ascendis Pharma A/S | — | NEW | New buy |